SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 8.40 |
| Enterprise Value ($M) | -13.14 |
| Book Value ($M) | 16.86 |
| Book Value / Share | 3.07 |
| Price / Book | 0.41 |
| NCAV ($M) | 16.47 |
| NCAV / Share | 3.00 |
| Price / NCAV | 0.51 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.63 |
| Return on Assets (ROA) | -0.39 |
| Return on Equity (ROE) | -0.43 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.90 |
| Current Ratio | 7.01 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 19.83 |
| Assets | 20.22 |
| Liabilities | 3.36 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 1.50 |
| Operating Income | -14.32 |
| Net Income | -12.96 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -13.56 |
| Cash from Investing | -0.02 |
| Cash from Financing | 14.82 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Stonepine Capital Management, LLC | 4.30 | -16.40 | |
| 13G/A | Sio Capital Management, LLC | 5.04 | -1.21 | |
| 13G | Nantahala Capital Management, LLC | 7.30 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 16,314 | 58,398 | 27.94 | |
| 4,382 | 31,068 | 14.10 | |
| 5,337 | 33,912 | 15.74 | |
| 7,651 | 27,533 | 27.79 | |
| 4,339 | 13,728 | 31.61 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ANEB – Anebulo Pharmaceuticals, Inc. | ANIX – Anixa Biosciences, Inc. |
| APM – Aptorum Group Limited | APVO – Aptevo Therapeutics Inc. |
| ARTL – Artelo Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io